Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Hawaii: The Complete Guide for Women, Families, and Survivors
For the women of Hawaii, the journey through breast reconstruction or aesthetic enhancement is often one of restoration and renewal. Whether you sought care at a major medical hub on Oahu like The Queen’s Medical Center or Kapi‘olani Medical Center for Women & Children, or you traveled from Maui, Kauai, or the Big Island to consult with specialists in Honolulu, the expectation was simple: a safe procedure with a device thoroughly vetted for your body. However, for many across our islands, that expectation has been met with the devastating reality of defective medical devices.
We at The Manginello Law Firm, PLLC, operating under the consumer brand Attorney911, understand the unique challenges facing Hawaii residents. When a medical device like a bioabsorbable scaffold or an acellular dermal matrix (ADM) fails, the isolation of the Pacific can make the search for justice feel even more distant. We are here to bridge that gap. With our Managing Partner Ralph Manginello — a veteran advocate with twenty-seven years of continuous practice since 1998 — and Associate Attorney Lupe Peña — who brings a unique insurance-defense background and offers full consultations in fluent Spanish — we provide the high-level federal litigation experience Hawaii patients need to hold multi-billion-dollar manufacturers accountable.
Understanding the Devices: What Was Implanted in Your Body?
Many Hawaii patients are surprised to learn that the products used to support their implants or tissue expanders were often used “off-label,” meaning they were never specifically cleared by the FDA for use in breast surgery. In Hawaii, where patients often have deep relationships with their surgical teams, it is important to distinguish the surgeon’s choices from the manufacturer’s failures. We focus our litigation on the companies that marketed these products as safe for your breast reconstruction while knowing the risks were higher than disclosed.
Acellular Dermal Matrix (ADM)
Often referred to in Hawaii surgical suites as “biologic mesh,” ADM is a tissue graft derived from human or animal skin. Common brands used in Hawaii include:
- AlloDerm and AlloDerm RTU (Allergan/AbbVie)
- Strattice (Allergan/AbbVie)
- FlexHD (MTF Biologics)
- AlloMax (Becton Dickinson/C.R. Bard)
These products are designed to act as a sling, supporting the weight of an implant. However, clinical data now shows that some brands, particularly FlexHD and AlloMax, have significantly higher rates of infection and reconstruction failure.
Bioabsorbable Scaffolds and “Internal Bras”
In cosmetic procedures frequently performed in aesthetic centers throughout Honolulu and Maui, surgeons may use a “scaffold” to provide an “internal bra” effect. These are synthetic but designed to be resorbed by your body. The most prominent examples include:
- GalaFLEX (Becton Dickinson/Tepha)
- Phasix (Becton Dickinson/C.R. Bard)
These devices are made of poly-4-hydroxybutyrate (P4HB). While the manufacturers claimed these would safely dissolve as your body’s own tissue took over, many Hawaii women have reported that the scaffolds did not dissolve as promised, leading to chronic pain, palpable ridges, and severe inflammatory responses.
The FDA’s Warning to Hawaii Healthcare Providers
The regulatory landscape transformed on November 9, 2023, when the FDA issued a critical letter to healthcare providers across the United States, including those practicing in Hawaii. The FDA stated clearly: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
This was a landmark moment for our clients in Hawaii. It confirmed that products like GalaFLEX and Phasix were being marketed and sold for breast surgery without ever having been studied or approved for that use. For a patient in Hawaii who underwent surgery three or four years ago and has since dealt with chronic redness or a “bottoming out” of her implant, this FDA letter provides the “discovery” needed to understand that the product—not her body’s healing process—may be the defect.
Why 510(k) Clearance Failed Hawaii Patients
At the heart of every breast mesh lawsuit we handle is a regulatory shortcut called the 510(k) clearance pathway. Unlike the rigorous Premarket Approval (PMA) process required for life-sustaining devices, the 510(k) pathway allows a company to sell a device if they can show it is “substantially equivalent” to a “predicate device” already on the market.
In the case of GalaFLEX, the manufacturer cited a surgical suture as one of its predicates. This “predicate creep” allowed a material never tested in human breast tissue to enter the operating rooms of Hawaii hospitals. Unlike generalist personal injury firms, we at Attorney911 understand the nuance of federal preemption. Under the Supreme Court’s ruling in Medtronic v. Lohr, 518 U.S. 470 (1996), 510(k)-cleared devices do not enjoy the same immunity from state-law suits that PMA-approved devices do. This means Hawaii survivors have a clear path to seek damages for the pain, suffering, and medical expenses caused by these shortcuts.
Complications and Warning Signs for Hawaii Survivors
If you are a Hawaii resident who received an “internal bra” or ADM-assisted reconstruction, you must be vigilant about the following symptoms. Complications can arise months or even many years after your procedure.
Red Breast Syndrome (RBS)
This is an ADM-specific sterile inflammation. Unlike a standard infection, RBS is an immunological reaction to endotoxins (bacterial fragments) left on the tissue during the manufacturing process. Hawaii patients often describe it as a bright, painless redness over the breast that does not respond to antibiotics. Research, including the landmark work by Nguyen et al. (2019), shows that this is often a brand-specific reaction that resolves only when the defective ADM is removed.
BIA-ALCL and BIA-SCC (Cancer Risks)
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a T-cell lymphoma (CD30 positive, ALK negative) that has been linked primarily to textured implant surfaces, such as the now-recalled Allergan BIOCELL products. Furthermore, the FDA’s March 2023 update warned of BIA-SCC (Squamous Cell Carcinoma), a distinct cancer found in the scar tissue capsule surrounding the implant. For patients in Hawaii, a late-onset swelling or lump near an old implant is a signal to seek immediate biopsy and pathology review.
Mechanical and Aesthetic Failure
We represent Hawaii women whose bioabsorbable scaffolds failed to provide the support promised, leading to:
- Skin-flap necrosis: Tissue death caused by compromised blood supply.
- Mesh extrusion: The device physically poking through the skin.
- Chronic neuropathic pain: Permanent nerve damage from the inflammatory response.
- Reconstruction loss: Being forced to abandon the reconstruction and undergo a “flat closure.”
The Whistleblower: Evidence of Concealment
Justice for Hawaii patients is strengthened by the testimony of people like Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson (the manufacturer of GalaFLEX and Phasix), Dr. Noorchashm became a whistleblower after raising safety concerns. He alleged that the manufacturer withheld data from the FDA regarding breast cancer recurrences in clinical trials and ignored the realities of adverse event reporting. When companies choose profits over the women of Hawaii, we use this evidence to fight for the maximum compensation possible.
Navigating the Law in Hawaii: Your Rights and Deadlines
Filing a product liability suit in Hawaii requires more than just filling out a form. Our firm, which is currently prosecuting high-profile multi-defendant litigation like Bermudez v. Pi Kappa Phi ( Harris County, Texas, $10,000,000 seeking damages), understands the structural requirements of suing massive corporations.
The Statute of Limitations in Hawaii
In Hawaii, the general statute of limitations for personal injury is two years from the date of the injury or the date the injury was discovered (HRS § 657-7). However, medical device cases are complex. If you are in Hawaii and only recently learned—perhaps through the 2023 FDA letter—that your mesh was never cleared for your surgery, your “discovery” clock may have only just started. It is vital to contact us at 1-888-ATTY-911 quickly to ensure your rights in Hawaii are protected.
Comparative Negligence
Hawaii follows a modified comparative negligence rule (the 51% rule). As long as you are not more than 50% responsible for your injury, you can recover damages, though they will be reduced by your percentage of fault. In device cases, the patient is almost never at fault; the focus remains on the manufacturer’s failure to warn.
Damages Available to Hawaii Residents
We aggressively pursue both economic and non-economic damages for our Hawaii clients:
- Medical Expenses: The cost of revision surgeries, explantations, and hyperbaric oxygen therapy.
- Financial Toxicity: Recent research shows breast reconstruction complications can add $7,000 or more in out-of-pocket costs within the first year.
- Pain and Suffering: The emotional toll of a failed reconstruction or a cancer diagnosis.
- Permanent Disfigurement: Compensation for the loss of the breast envelope or sensory loss.
The Attorney911 Advantage for Hawaii Patients
Why should a woman in Hawaii choose a firm managed by Ralph Manginello and supported by Lupe Peña? For twenty-seven years, Ralph has built a reputation for standing up to institutional defendants. Our firm holds a 4.9 out of 5.0 rating across hundreds of reviews on Birdeye and an “Excellent” 8.2 rating on Avvo. We are admitted to practice in the United States District Court for the Southern District of Texas, and we maintain the capability to handle federal device litigation nationwide.
For the many families in Hawaii who speak Spanish, Lupe Peña provides a direct line of communication. We believe that no Hawaii survivor should have to navigate a complex legal battle through an interpreter. Lupe conducts full consultations in fluent Spanish, ensuring your story is heard exactly as you tell it.
We work on a contingency-fee basis. This means there is no upfront cost for our Hawaii clients. We only get paid if we recover compensation for you. This removes the barrier to justice for patients traveling from the neighbor islands or those already burdened by medical debt.
Frequently Asked Questions for Hawaii Residents
1. Is it too late to file if my surgery was in Honolulu five years ago?
Not necessarily. Hawaii’s discovery rule may allow you to file if you only recently understood the connection between your device and your symptoms. Many Hawaii women are only now discovering the risks through new FDA safety communications.
2. I live on Maui. Do I need to travel to a mainland office to hire you?
No. We handle intakes for Hawaii residents virtually and via phone (1-888-ATTY-911). We can manage your case across the Pacific, coordinating with your Hawaii medical team to gather records and pathology slides.
3. Will I have to sue my Hawaii surgeon?
Our primary focus is the manufacturer of the defective mesh or scaffold. While every case is different, most Hawaii litigation in this field centers on the company that failed to warn both you and your surgeon about the device’s risks.
4. What if my insurance in Hawaii won’t cover my explant surgery?
We examine the legal implications of coverage denials. Under the Women’s Health and Cancer Rights Act of 1998, insurers that cover mastectomies must generally cover the treatment of complications. We fight to ensure the manufacturer’s negligence doesn’t leave you with the bill.
5. How do I find out what brand of mesh was used at my Hawaii hospital?
You have a legal right to your operative reports in Hawaii. We can help you request these records and look for the “implant stickers” or Unique Device Identifiers (UDI) that name the brand and lot number of the device used.
Essential Next Steps for Hawaii Survivors
If you are experiencing symptoms or have been diagnosed with BIA-ALCL or BIA-SCC in Hawaii, take these steps immediately:
- Request your Operative Report: Contact the medical records department at your Hawaii surgical center.
- Preserve the Evidence: If you are undergoing a revision surgery, have your Hawaii attorney send a “preservation letter” to the pathology lab to ensure the removed mesh or scaffold is not destroyed.
- Check the Recalls: Verify if your implants are on the Allergan BIOCELL list or if your mesh is part of the BD labeling update.
- Contact Attorney911: Call 1-888-ATTY-911 for a free, confidential consultation.
Dedicated to the Future of Hawaii’s Survivors
The islands of Hawaii represent resilience, but no one should have to be resilient in the face of corporate negligence alone. Whether you are navigating life after a mastectomy in Pearl City, seeking answers after an aesthetic revision in Wailea, or grieving a loss on the Big Island, we are dedicated to providing the technical authority and compassionate education you deserve.
The manufacturers of these defective scaffolds and meshes had a duty to the women of Hawaii. They failed. We are here to make it right. Ralph Manginello’s twenty-seven years of practice and our firm’s verifiable record of high-profile litigation give you the leverage you need to face these companies.
Hablamos español. Lupe Peña and our entire team are ready to listen to your story. Contact us today at 1-888-ATTY-911 to begin your journey toward justice in Hawaii.
Results and past performance do not guarantee a future outcome. Every case in Hawaii is unique and depends on the specific medical and legal facts involved. This content is for educational purposes and does not constitute medical or legal advice. Please consult with a licensed Honolulu healthcare provider for medical concerns and contact us for a formal legal consultation.
